Literature DB >> 23351837

Methamphetamin abuse a new concern in Iran.

Omid Mehrpour1.   

Abstract

Entities:  

Year:  2012        PMID: 23351837      PMCID: PMC3556003          DOI: 10.1186/2008-2231-20-73

Source DB:  PubMed          Journal:  Daru        ISSN: 1560-8115            Impact factor:   3.117


× No keyword cloud information.

Sir

I read with great interest the recent article published by Sadeghi et al., "Report of methamphetamine use and cardiomyopathy in three patients" [1]. The authors state that" cardiomyopathy and acute heart failure may be a new medical concern". Methamphetamine induced cardiomyopathy is certainly a medical concern, and while it is not often reported in Iran, it is a well described clinical finding in the medical literature. Wijetunga et al. retrospectively reviewed 21 crystal methamphetamine hospitalized cases and found that 84% of patients had dilated cardiomyopathy and global ventricular dysfunction in echocardiography. They also concluded that the pathogenesis is probably similar to that of cocaine and catecholamine-induced cardiomyopathy [2]. Moreover, Yeo et al. in a study on 107 cases of cardiomyopathy found that methamphetamine users had a 3.7-fold increased odds ratio for cardiomyopathy, adjusting for age, body mass index, and renal failure. In their retrospective study, 40% of patients under the age of 40 with cardiomyopathy had a history of recent methamphetamine abuse [3]. In addition, as the authors have mentioned, the use of methamphetamine has grown significantly in Iran over the past few years. Complicating the monitoring of drug abuse trends is the street names of illicit drugs are unique to Iran. For exam, Iranian crystal is marketed to Iranian youngsters and the main ingredient is heroin. In central and western Iran, methamphetamine may also be added to this opiate-based drug. Some Iranian addicts (and perhaps researchers) believe that the crystal is actually crystal-meth (amphetamine base) because of the similarity in names [4]. Shishe is another common street drug name in Iran and the main ingredient is methamphetamine. Iran has the highest rate of opioid drugs addicts in the world [4-6] and with Iranian crystal exposure to methamphetamine may be increasing. Crystal meth and Shishe are also now widely abused. With the increasing use of methamphetamine, both knowingly (in the cases of crystal-meth and Shishe) and unknowingly (in the case of Iranian Crystal), it is likely that we will see more cases of drug induced cardiomyopathy in the country.
  5 in total

1.  Diagnostic imaging in body packers.

Authors:  Omid Mehrpour; Seyed Vahid Sezavar
Journal:  Mayo Clin Proc       Date:  2012-07       Impact factor: 7.616

2.  The association of methamphetamine use and cardiomyopathy in young patients.

Authors:  Khung-Keong Yeo; Mevan Wijetunga; Hiroki Ito; Jimmy T Efird; Kevin Tay; Todd B Seto; Kavitha Alimineti; Chieko Kimata; Irwin J Schatz
Journal:  Am J Med       Date:  2007-02       Impact factor: 4.965

3.  Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?

Authors:  Mevan Wijetunga; Todd Seto; Joseph Lindsay; Irwin Schatz
Journal:  J Toxicol Clin Toxicol       Date:  2003

4.  Report of methamphetamine use and cardiomyopathy in three patients.

Authors:  Roxana Sadeghi; Khosro Agin; Maryam Taherkhani; Leila Najm-Afshar; Lewis S Nelson; Mohammad Abdollahi; Shahin Shadnia
Journal:  Daru       Date:  2012-08-30       Impact factor: 3.117

5.  Iranian Crystal: A misunderstanding of the crystal-meth.

Authors:  Parissa Karrari; Omid Mehrpour; Mahdi Balali-Mood
Journal:  J Res Med Sci       Date:  2012-02       Impact factor: 1.852

  5 in total
  13 in total

1.  Treatment of amphetamine abuse/use disorder: a systematic review of a recent health concern.

Authors:  Mansour Khoramizadeh; Mohammad Effatpanah; Alireza Mostaghimi; Mehdi Rezaei; Alireza Mahjoub; Sara Shishehgar
Journal:  Daru       Date:  2019-06-21       Impact factor: 3.117

2.  Treating methamphetamine-induced resistant psychosis with clozapine.

Authors:  Ruohollah Seddigh; Amir-Abbas Keshavarz-Akhlaghi; Behnam Shariati
Journal:  Case Rep Psychiatry       Date:  2014-10-28

Review 3.  A hospital base epidemiology and pattern of acute adult poisoning across Iran: a systematic review.

Authors:  Malihe Moradi; Kazem Ghaemi; Omid Mehrpour
Journal:  Electron Physician       Date:  2016-09-20

Review 4.  A systematic review of the cardiotoxicity of methadone.

Authors:  Samira Alinejad; Toba Kazemi; Nasim Zamani; Robert S Hoffman; Omid Mehrpour
Journal:  EXCLI J       Date:  2015-05-05       Impact factor: 4.068

5.  Histopathological study of cardiac lesions in methamphetamine poisoning-related deaths.

Authors:  Maryam Akhgari; Homeira Mobaraki; Afshar Etemadi-Aleagha
Journal:  Daru       Date:  2017-02-17       Impact factor: 3.117

6.  Determination of the role of calcium on instability of neurotoxic metabolite of ecstasy by HPTLC-mass.

Authors:  Bardia Jamali; Yalda Hosseinzadeh Ardakani; Mohammad-Reza Rouini; Alireza Foroumadi; Salimeh Amidi; Vahid Hossein Zadeh Aghdam; Farzad Kobarfard
Journal:  Daru       Date:  2013-01-17       Impact factor: 3.117

7.  Methamphetamine-associated psychosis: a new health challenge in Iran.

Authors:  Zahra Alam Mehrjerdi; Alasdair M Barr; Alireza Noroozi
Journal:  Daru       Date:  2013-04-11       Impact factor: 3.117

8.  Crystal in Iran: methamphetamine or heroin kerack.

Authors:  Zahra Alam Mehrjerdi
Journal:  Daru       Date:  2013-03-15       Impact factor: 3.117

9.  Effectiveness of Electroconvulsive Therapy in Persistent Methamphetamine Psychosis: A Pilot Study.

Authors:  Hassan Ziaaddini; Toktam Roohbakhsh; Nouzar Nakhaee; Alireza Ghaffari-Nejad
Journal:  Addict Health       Date:  2015 Winter-Spring

Review 10.  A Narrative Review of Acute Adult Poisoning in Iran.

Authors:  Samira Alinejad; Nasim Zamani; Mohammad Abdollahi; Omid Mehrpour
Journal:  Iran J Med Sci       Date:  2017-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.